نتایج جستجو برای: eox regimen

تعداد نتایج: 46264  

2014
WENJUN CHEN JIANGUO SHEN TAO PAN WENXIAN HU ZINONG JIANG XIAOMING YUAN LINBO WANG

Neoadjuvant chemotherapy is the preferred treatment of advanced gastric cancer. However, the choice of an optimal regimen remains controversial. The present study aimed to assess the effectiveness of preoperative chemotherapy with EOX and FOLFOX in Chinese patients with advanced gastric cancer. A total of 87 and 26 patients underwent FOLFOX and EOX regimens, respectively, for advanced gastric c...

Journal: :iranian journal of radiation research 0
f. samiei department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran a. maddah safaei department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran e. esmati department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran a. alibakhshi department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran ms. mirai ashtiani department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran p. haddad department of radiation oncology, cancer institute, imam khomeini hospital, tehran, iran

background: gastric cancer is an important health problem across the world. chemotherapy in combination with local treatment is standard treatment for locally advanced gastroesophageal cancers. the purpose of this investigation was evaluation of response and tolerability to neoadjuvant eox regimen in locoregionally advanced gastric cancer. materials and methods: patients with locoregionally adv...

2016
Yan Wang Rong-yuan Zhuang Yi-yi Yu Shan Yu Jun Hou Yuan Ji Yi-hong Sun Kun-tang Shen Zhen-bin Shen Feng-lin Liu Nai-qing Zhao Tian-shu Liu

Purpose We assessed the effectiveness of EOX (capecitabine, oxaliplatin and epirubicin) compared with XELOX (capecitabine and oxaliplatin) as preoperative chemotherapy for initially unresectable locally advanced gastric cancer.Methods This is a prospective observational study. Patients with unresectable locally advanced gastric cancer were performed EOX regimen or XELOX regimen at the discretio...

2015
Sebastian Ochenduszko Miroslawa Puskulluoglu Kamil Konopka Kamil Fijorek Katarzyna Urbanczyk Andrzej Budzynski Maciej Matlok Agata Lazar Anna Sinczak-Kuta Michal Pedziwiatr Krzysztof Krzemieniecki

The aim of the study was to compare efficacy and safety of first-line palliative chemotherapy with (EOX) epirubicin/oxaliplatin/capecitabine and (mDCF) docetaxel/cisplatin/5FU/leucovorin regimens for untreated advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma. Fifty-six patients were randomly assigned to mDCF (docetaxel 40 mg/m(2) day 1, leucovorin 400 mg/m(2) day 1, 5F...

A. Alibakhshi, A. Maddah Safaei, E. Esmati, F. Samiei, H. Nosrati, MS. Mirai Ashtiani, N. Khanjani, P. Haddad,

Background: Gastric cancer is an important health problem across the world. Chemotherapy in combination with local treatment is standard treatment for locally advanced gastroesophageal cancers. The purpose of this investigation was evaluation of response and tolerability to neoadjuvant EOX regimen in locoregionally advanced gastric cancer. Materials and Methods: patients with locoregionally adv...

حداد, پیمان, سمیعی, فرهاد, عصمتی, ابراهیم, علی‌بخشی, عباس, مداح صفایی, افسانه, میرایی آشتیانی, منیر سادات,

Background: Gastric cancer is an important health problem across the world. Chemotherapy in combination with local treatment is the standard treatment for locally advanced gastroesophageal junction (EGJ) cancers. The purpose of this study was to evaluate response and tolerability to neoadjuvant regimen combining epirobicin, oxaliplatin and capecitabin (EOX) in locoregionally advanced gastric ca...

2015
N. Khanjani

Background: Gastric cancer is an important health problem across the world. Chemotherapy in combina on with local treatment is standard treatment for locally advanced gastroesophageal cancers. The purpose of this inves ga on was evalua on of response and tolerability to neoadjuvant EOX regimen in locoregionally advanced gastric cancer. Materials and Methods: pa ents with locoregionally advanced...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2015
Pedro Nazareth Aguiar Junior Christian Ribas Nora Manoukian Forones

BACKGROUND Despite the decreased incidence, gastric cancer is still a frequent cause of cancer related death. The 1st line 2 or 3 drugs regimen is still a debatable issue. HER2 targeted therapy has emerged as the standard of care, but it is unavailable in the Brazilian Public Health System. The end-point of this trial was overall survival (OS) in patients with metastatic gastric cancer treated ...

2015
Zhen-Feng Wu Qin-Hong Cao Xiao-Yu Wu Che Chen Zhe Xu Wei-Su Li Xue-Quan Yao Fu-Kun Liu

To identify clinicopathologic and treatment variables that could predict pathologic tumor response to short-term neoadjuvant chemotherapy (NAC) for patients with locally advanced gastric cancer. A retrospective analysis was conducted of 178 patients who underwent short-term NAC with EOX regimen followed by surgery from January 2008 to December 2010. Neoadjuvant treatment response was evaluated ...

2015
Ann-Christin E. Brehler Wolfgang Hartmann Stefanie Wiebe Andrea Kerkhoff Christoph Schliemann Daniel Palmes Norbert Senninger Frank Lenze Hansjoerg Ullerich Wolfgang E. Berdel Torsten Kessler

BACKGROUND Perioperative chemotherapy increases the overall and progression-free survival of patients suffering from resectable adenocarcinomas of the lower esophagus, gastroesophageal junction and stomach (GEC). Comparing different chemotherapy regimens platin-based protocols with 5-fluorouracil (5-FU)/calcium folinate (CF) or oral fluoropyrimidines were favorable in terms of efficacy and side...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید